CARMA FUND
Venture capital
RollingLast verified 7 Nov 2026
Munich-based venture capital firm investing in European early-stage life science and healthcare companies across therapeutics, medtech, diagnostics, and digital health.
2 deals in the last 24 months, latest 20 Jan 2026. From its website and its deals in the news.
Key facts
- Stages
- Pre-seed, Seed, Series A, Series B
- Sectors
- Biotech & pharma, Medtech, Healthtech
- Eligible countries
- Not stated
- Provider based in
- Germany
- Timing
- Rolling applications
- Focus
- European life sciences; therapeutics; medtech; diagnostics; digital health
- How to apply
- Pitch by email · Apply on their site
Recent deals
Evidence
Short excerpts from the sources, in their original language, that back the facts above.
- Apply link
http://www.carma-fund.com/ | www.carma-fund.com
https://www.goingpublic.de/partner/carma-fund - Kind
CARMA FUND I is uniquely suited for young Eurpean companies and projects from the Life Science and medical space due to an extra-long term, flexible…
https://www.goingpublic.de/partner/carma-fund - Sectors
Industry focus CARMA FUND is investing in opportunities from the European Life Science and Healthcare sector. THERAPEUTICS MEDTECH DIAGNOSTICS DIGITAL HEALTH
https://www.goingpublic.de/partner/carma-fund - Stages
CARMA invests in pre-seed, seed, and series A.
https://www.goingpublic.de/partner/carma-fund
Status history
- 7 Nov 2026: Uncertain → Rolling (profiles: investor activity)
- 7 Nov 2026: Rolling → Uncertain (freshness: investor activity)
- 6 Nov 2026: Rolling (first extraction)
Something wrong or out of date? Report an error.
Work at CARMA FUND? Claim this profile to confirm what you invest in.